FTC Releases Second Interim Staff Report on Prescription Drug Middlemen
1 day ago · The Federal Trade Commission today published a second interim staff report on the prescription drug middleman industry, which focuses on pharmacy benefit managers’ (PBMs) influence over specialty generic drugs, including significant price markups by PBMs for cancer, HIV, and a variety of other critical drugs.
Top three insurers reaped $7.3 billion through their drug middlemen…
1 day ago · The three largest drug middlemen inflated the costs of numerous life-saving medications by billions of dollars over the past few years, ... Cancer drugs alone made up nearly half of the $7.3 ...
FTC finds middlemen inflate specialty generic drug prices by
1 day ago · Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...
FTC Says CVS, Cigna and UnitedHealth Abuse Middleman Role - Bloomberg.com
1 day ago · Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average acquisition cost for dozens of specialty generic drugs, bringing in more ...
FTC Releases Interim Staff Report on Prescription Drug Middlemen
The Federal Trade Commission today published an interim report on the prescription drug middleman industry that underscores the impact pharmacy benefit managers (PBMs) have on the accessibility and affordability of prescription drugs.
FTC Sues Prescription Drug Middlemen for Artificially Inflating …
Sep 20, 2024 · The FTC alleges that the three PBMs created a perverse drug rebate system that prioritizes high rebates from drug manufacturers, leading to artificially inflated insulin list prices.
Drug middlemen inflate US prices, squeeze out competition, FTC …
Jul 9, 2024 · Firms that serve as intermediaries to negotiate and control prescription drug access in the US "wield enormous power," largely with "extraordinarily opaque" business practices, and may be...
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
Sep 20, 2024 · The Federal Trade Commission said on Friday that it had taken legal action against the three largest pharmacy benefit managers, accusing the drug middlemen of inflating insulin prices and...
FTC Report Shows Big Pharma Middlemen Jack Up Prices by Up …
1 day ago · The U.S. Federal Trade Commission on Tuesday published the second part of its investigation into how prescription drug middlemen are marking up the prices of specialty generic drugs dispensed at their affiliated pharmacies by hundreds—and in some cases, thousands—of percent, underscoring what advocates say is the need for urgent action by policymakers.
Federal Trade Commission sues largest drug middlemen for
Sep 20, 2024 · The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in...